• Expertise
  • Ingredient Solutions
  • Applications
  • Resources
    Resources
  • PLT People & Planet
  • About
    About

    Our international network, passionate team of experts and extensive industry knowledge is what sets us apart.

    Seth circle headshot
    Seth Flowerman
    President and CEO
Clinical Research

Improvement of High-Fat Diet-Induced Obesity by Xanthigen® in C57BL/6N Mice

Improvement of High-Fat Diet-Induced Obesity by Xanthigen® in C57BL/6N Mice

Choi, Kyeong-Mi & Lee, Youn-Sun & Kim, Wonkyun & Choi, Yung-Hyun & Kwak, Youn-Gil & Jung, Jae-Chul & Lee, Jeongrai & Yoo, Hwan-Soo

(2012) JOURNAL OF LIFE SCIENCE. 22. 1697-1703. 10.5352/JLS.2012.22.12.1697.

Abstract

Obesity is a risk factor for numerous metabolic diseases. Recently, naturally occurring compounds that may improve obesity have received increasing attention. Xanthigen is a mixture of fucoxanthin and punicic acid derived from brown seaweed and pomegranate seed, respectively, which were traditionally used for lipid-lowering effects in humans. In this study, we investigated whether Xanthigen attenuates high-fat diet-induced obesity in C57BL/6N mice. The mice were fed on a normal diet (ND), high-fat diet (HFD), HFD plus 1% Xanthigen or HFD plus 1% green tea extract (GTE) for 11 weeks. Food efficiency ratio (FER) and body weight of mice fed HFD plus Xanthigen was significantly reduced compared to that in HFD-fed mice. Consistent with the results in body weight change, Xanthigen also significantly decreased the weights of epididymal adipose tissue, retroperitoneal adipose tissue, and liver in HFD plus 1% Xanthigen-fed mice. Serum level of low-density lipoprotein (LDL)-cholesterol in HFD plus Xanthigen-fed mice was significantly decreased compared to that in HFD-fed mice. These results suggest that Xanthigen may be useful in the development of functional health food for anti-obesity.

Request a Copy of The Clinical Trial